CADM1: A molecule worth investigating in mycosis fungoides and Sézary syndrome - 13/03/20
Doi : 10.1016/j.jaad.2019.11.067
Shiyu Zhang, MD, Tao Wang, MD ⁎ 
, Yuehua Liu, MD
, Yuehua Liu, MD Department of Dermatology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China
∗Correspondence to: Tao Wang, MD, Department of Dermatology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 1 Shuaifuyuan, Wangfujing, Beijing, ChinaDepartment of DermatologyPeking Union Medical College HospitalPeking Union Medical College and Chinese Academy of Medical SciencesNo. 1 Shuaifuyuan, WangfujingBeijingChina
Le texte complet de cet article est disponible en PDF.
| Funding sources: 1. Fundamental Research Funds for the Central Universities (3332018025), 2. National Scientific Data Sharing Platform for Population and Health - Clinical Center (NCMI-ABD02-201709), 3. Beijing Dongcheng District Excellent Talent Support Training project (2019JGM-5), 4. Peking Union Medical College Postgraduate Innovation Fund (2019-1002-72). |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Not applicable. |
|
| Reprints not available from the authors. |
© 2019
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 82 - N° 4
P. e141-e142 - avril 2020 Retour au numéro
Article précédent
- Reply to: “Studies on the role of diet in the management of hidradenitis suppurativa are needed”
- Maria Melendez-Gonzalez, Mirza Alikhan, Christopher J. Sayed
- CADM1 expression of mast cells in mycosis fungoides
- Akihiko Yuki, Osamu Ansai, Riichiro Abe
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?